Table 3 Standardized scores by domains of AGREE II
Guideline | Scope and Purpose | Stakeholder Involvement | Rigour of Development | Clarity of Presentation | Applicability | Editorial Independence | Overall Recommendation |
|---|---|---|---|---|---|---|---|
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis [28] | 94.44 | 30.56 | 60.42 | 83.33 | 25.00 | 75.00. | Recommended, with modifications |
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents [29] | 75.00 | 36.11 | 57.29 | 86.11 | 18.75 | 33.33 | Recommended, with modifications |
ACG Clinical Guideline: Management of Crohn’s Disease in Adults [30] | 44.44 | 5.56 | 35.42 | 72.22 | 4.17 | 29.17 | Not recommended |
European evidence based consensus on surgery for ulcerative colitis [31] | 75.00 | 36.11 | 50.00 | 66.67 | 6.25 | 29.17 | Recommended, with modifications |
Updated German Clinical Practice Guideline on “Diagnosis and treatment of Crohn’s disease” 2014 [32] | 91.67 | 86.11 | 83.33 | 61.11 | 12.50 | 91.67 | Recommended, with modifications |
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease [33] | 72.22 | 52.78 | 61.46 | 83.33 | 12.50 | 12.50 | Recommended, with modifications |
Management of paediatric ulcerative colitis, Part 1: ambulatory care- an evidence-based guideline from ECCO and ESPGHAN [34] | 83.33 | 27.78 | 67.71 | 83.33 | 6.25 | 66.67 | Recommended, with modifications |
Evidence-based clinical practice guidelines for Crohn’s disease, integrated with formal consensus of experts in Japan [35] | 91.67 | 52.78 | 56.25 | 94.44 | 16.67 | 79.17 | Recommended, with modifications |
Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn’s and Colitis Organisation [36] | 75.00 | 30.56 | 60.42 | 69.44 | 12.50 | 50.00 | Recommended, with modifications |
Mexican consensus for the diagnosis and treatment of idiopathic chronic ulcerative colitis [37] | 36.11 | 19.44 | 50.00 | 63.89 | 6.25 | 62.50 | Not recommended |
Crohn’s disease Management in adults, children and young people [38] | 94.44 | 83.33 | 94.79 | 100.00 | 83.33 | 75.00 | Recommended |
Second Korean guidelines for the management of ulcerative colitis [39] | 80.55 | 58.33 | 71.88 | 100.00 | 22.92 | 29.17 | Recommended, with modifications |
AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis [40] | 100.00 | 80.56 | 91.67 | 100.00 | 56.25 | 83.33 | Recommended |
Evidence-based clinical practice guidelines for inflammatory bowel disease [41] | 91.66 | 75.00 | 82.29 | 88.89 | 58.33 | 83.33 | Recommended, with modifications |
Ulcerative colitis - treatment with biologicals [42] | 88.88 | 33.33 | 45.83 | 55.56 | 6.25 | 0.00 | Not recommended |
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults [43] | 100.00 | 100.00 | 91.67 | 100.00 | 45.83 | 100.00 | Recommended |
Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease [44] | 100.00 | 94.44 | 85.42 | 100.00 | 25.00 | 95.83 | Recommended |
Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus [45] | 86.11 | 91.67 | 79.17 | 100.00 | 14.58 | 95.83 | Recommended, with modifications |
Crohn’s disease - treatment with biological medication [46] | 80.55 | 44.44 | 34.38 | 44.44 | 4.17 | 0.00 | Not recommended |
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease [47] | 100.00 | 91.67 | 90.63 | 100.00 | 37.50 | 91.67 | Recommended |
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 [48] | 77.78 | 66.67 | 66.67 | 91.67 | 18.75 | 87.50 | Recommended, with modifications |
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease [49] | 94.44 | 83.33 | 87.50 | 100.00 | 52.08 | 91.67 | Recommended |
WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting [50] | 86.11 | 69.44 | 63.54 | 91.67 | 25.00 | 50.00 | Recommended, with modifications |
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update [51] | 91.67 | 66.67 | 86.46 | 100.00 | 39.58 | 100.00 | Recommended, with modifications |
Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology [52] | 94.44 | 72.22 | 71.88 | 91.67 | 33.33 | 0.00 | Recommended, with modifications |
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment [53] | 91.67 | 94.44 | 92.71 | 97.22 | 47.92 | 100.00 | Recommended |
Mean Score | 84.51 | 60.90 | 69.95 | 85.58 | 26.60 | 62.02 | |
Median | 90.27 | 66.67 | 69.79 | 91.67 | 20.83 | 75.00 |